Eotaxin-3, as a marker for eosinophilic esophagitis and methods of assessing, mitigating, and monitoring eosinophilic esophagitis by altering eotaxin-3 and/or CCR3 function, are disclosed.
申请公布号
WO2006083390(A3)
申请公布日期
2006.12.07
申请号
WO2005US44456
申请日期
2005.12.07
申请人
CHILDREN'S HOSPITAL MEDICAL CENTER;ROTHENBERG, MARC, ELLIOT